5-Amino-1MQ

Name: 5-Amino-1MQ Research Compound | NNMT Inhibitor | Small-Molecule
Price: 89.00 USD
Availability: InStock

$89.00

Per vial

$8.90

10 vials per pack

Suggested retail

$26.70

3× markup · per vial

Envío gratuito en pedidos superiores a $2,000

$300 store credit on any independent COA · results don't matter

Miligramos por vial

Warehouse

Borrar

Garantía de entrega Reenvío gratuito si no llega
Pureza ≥99 % Producción directa del fabricante
Certificados de análisis independientes Ver certificados de análisis de este producto →
Garantía de crédito en tienda Envía cualquier resultado de COA y obtén crédito en la tienda

5-Amino-1MQ - Selective NNMT Inhibitor Research Compound

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule selective inhibitor of NNMT (nicotinamide N-methyltransferase), first published by Neelakantan and colleagues in 2017. Unlike most compounds WWP stocks, 5-Amino-1MQ is not a peptide - it is a membrane-permeable small molecule that blocks a specific methylation enzyme. Its research profile is built around adipose-tissue metabolism, NAD+ pool regulation, and methyl-donor flux. It is most often compared to NAD+ and NAD+ precursors because both affect the same pyridine-nucleotide pool, just from opposite directions.

Why NNMT Inhibition Matters

NNMT methylates nicotinamide (NAM) to form 1-methylnicotinamide (MNA), using S-adenosylmethionine (SAM) as the methyl donor. The reaction sinks both NAM and SAM - two metabolically central substrates. In adipose tissue, elevated NNMT activity correlates with obesity and insulin resistance. Blocking NNMT with 5-Amino-1MQ preserves the NAM pool (feeds back into NAD+ salvage) and spares SAM (improves methylation flux elsewhere). That is the mechanistic rationale behind the published adipose-tissue and body-composition research on the compound.

Itinerario	En pocas palabras, esto es lo que hace
NNMT enzyme	Inhibited - nicotinamide no longer methylated and excreted
NAD+ salvage pathway	Preserved NAM feeds back into NAD+ recycling
SAM / methyl-donor pool	Spared - not consumed by the NNMT reaction
Adipocyte energy expenditure	Increased lipolysis reported in published in-vitro and rodent work

5-Amino-1MQ vs NAD+ / NR / NMN

All four compounds influence the NAD+ pool, but they act at different points in the pathway.

Compuesto	Mecanismo
5-Amino-1MQ	Inhibits NNMT - blocks NAM excretion, preserves NAD+ precursor pool
NAD+ (direct)	Supplies the cofactor directly - bypasses salvage pathway
NR (nicotinamide riboside)	Precursor - enters the salvage pathway one step upstream of NAD+
NMN (nicotinamide mononucleotide)	Precursor - enters the salvage pathway two steps upstream of NAD+

5-Amino-1MQ is unique among them because it does not supply any precursor - it blocks the enzyme that drains the pool.

Aplicaciones de investigación

5-Amino-1MQ is used in studies examining:

NNMT activity and selective enzyme inhibition
NAD+ / NAM pool regulation and salvage-pathway flux
Adipose-tissue metabolism and lipolysis endpoints
SAM / methyl-donor pool research
Insulin-sensitivity and body-composition models
Comparative research vs. NAD+, NR, and NMN

Especificaciones


Formato	Polvo liofilizado
Pureza	≥99%
Alias	5-Amino-1-methylquinolinium iodide, 5A1MQ, NNMT inhibitor
Clase molecular	Molécula pequeña (no es un péptido)
Almacenamiento	2-8 °C sin abrir; estable durante más de 12 meses
Uso	Research purposes only - not for human use

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for 5-Amino-1MQ are documented in the published peer-reviewed literature and standard peptide-chemistry references.

Reference Literature

Published clinical and preclinical 5-Amino-1MQ literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.

Common Questions About 5-Amino-1MQ Research

What does 5-Amino-1MQ do in research?

It selectively inhibits NNMT, the enzyme that methylates nicotinamide into 1-methylnicotinamide. Blocking NNMT preserves the NAM pool (feeds back into NAD+ salvage) and spares the SAM methyl-donor pool. Downstream, published work tracks adipose-tissue lipolysis, insulin sensitivity, and body-composition endpoints.

What is the difference between 5-Amino-1MQ and NAD+?

They influence the same NAD+ pool from opposite directions. NAD+ supplies the cofactor directly; 5-Amino-1MQ inhibits the enzyme that drains the precursor pool. NR and NMN are precursors that feed the salvage pathway. Combination research exists because the mechanisms are complementary rather than redundant.

Is 5-Amino-1MQ a peptide?

No. 5-Amino-1MQ is a small-molecule quinolinium derivative, not a peptide. It is the only non-peptide research compound in most “peptide” research catalogs, and it is included because its NAD+/NNMT research axis overlaps heavily with peptide-adjacent longevity and body-composition literature.

Is 5-Amino-1MQ FDA approved?

No. 5-Amino-1MQ is not FDA approved for any use. It is a research compound only. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is 5-Amino-1MQ stored?

Los viales sin abrir se conservan a una temperatura de entre 2 y 8 °C y se mantienen estables durante más de 12 meses. Una vez reconstituida con agua bacteriostática, la solución se conserva a una temperatura de entre 2 y 8 °C y debe utilizarse en un plazo de 28 a 30 días.

Garantía de pureza

Cada lote tiene una pureza ≥99 %. Envíanos un certificado de análisis (COA) de cualquier análisis independiente y te daremos un vale de compra, independientemente de lo que indique.